iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Lupin acquires Portfolio of products worth Rs325cr of Anglo-French Drugs -; Industries

18 Jan 2022 , 01:56 PM

Lupin Ltd.’s share gained over 1% after its announcement to acquire a portfolio of Brands of Anglo-French Drugs & Industries & associates, to strengthen its portfolio in vitamins, supplements, and minerals. 

The portfolio of products that is being acquired falls within the business line of the company and will enable the addition of established brands with high recall amongst healthcare professionals, especially in the Minerals, Vitamins, and supplements category.

This will create new value for the company and would lead to EBITDA margin accretion, the company said in the filing.

The acquisition will be completed by March 2022. Company is paying a consideration of about Rs 325 crores including working capital amounting to Rs 9 crores, partly on cash and debt basis.

To be precise, the acquisition is only of a portfolio of products and not any unit or division of the company.

Lupin Ltd is currently trading at Rs952.85 up by Rs10.3 or 1.09% from its previous closing of Rs942.55 on the BSE. The scrip opened at Rs942 and has touched a high and low of Rs961.50 and Rs936.80 respectively. 

Related Tags

  • Lupin Acquisition
  • Lupin News
  • Lupin Stock
  • Lupin Updates
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.